2025 Market Access Guide for Biotech: What is essential and what is a waste of resources
In the competitive and resource-constrained world of biotechnology, achieving market access and reimbursement is critical.
In the competitive and resource-constrained world of biotechnology, achieving market access and reimbursement is critical.
The implementation of the Joint Clinical Assessment (JCA) in the European Union represents a notable
On July 4, 2024, the Bundestag (German Parliament) passed significant amendments to the country’s drug
What you need to know about confidential discounts and net prices in EU-5 In the
The new Joint Clinical Assessment (JCA) and Joint Scientific Consultation (JSC) initiatives, which are part
In Francia, i Programmi di Accesso Precoce Rimborsati (EAP) consentono il rimborso di nuovi farmaci
Justin Stindt Consultants è una società di consulenza in rapida crescita che offre servizi di consulenza strategica e di accesso al mercato a clienti leader del settore farmaceutico, biotecnologico e dei dispositivi medici. Operiamo in Europa e negli Stati Uniti.
